Technical Analysis for CNCE - Concert Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 11.55 1.32% 0.15
CNCE closed up 1.32 percent on Tuesday, June 25, 2019, on 74 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CNCE trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Touch Strength 0.00%
Gilligan's Island Sell Setup Bearish Swing Setup 1.32%
Gapped Up Strength 1.32%
Upper Bollinger Band Touch Strength 1.32%
20 DMA Support Bullish 5.87%
Upper Bollinger Band Touch Strength 4.52%
MACD Bullish Centerline Cross Bullish 3.03%
Outside Day Range Expansion 3.03%
NR7 Range Contraction 5.19%
Inside Day Range Contraction 5.19%

Older signals for CNCE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Concert Pharmaceuticals, Inc., a biotechnology company, develops drug candidates. Its drug candidates address various therapeutic areas, including hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, schizophrenia, multiple tumors, and hyperparathyroidism, as well as provide agents for diabetic nephropathy and other forms of chronic kidney diseases. The company also develops CTP-354, a GABA(A) receptor subtype-selective modulator for the treatment of spasticity and chronic pain. Concert Pharmaceuticals, Inc. has strategic alliances with GlaxoSmithKline plc and Celgene Corporation. The company was founded in 2006 and is based in Lexington, Massachusetts.
Medicine Biotechnology Medical Specialties Life Sciences Pain New Jersey Schizophrenia Chronic Kidney Disease Tumors Chronic Pain HIV Kidney Diseases Celgene Diabetic Nephropathy Bristol Myers Squibb Summit
Is CNCE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.87
52 Week Low 9.21
Average Volume 214,589
200-Day Moving Average 13.1674
50-Day Moving Average 10.5472
20-Day Moving Average 10.8155
10-Day Moving Average 11.023
Average True Range 0.6447
ADX 18.1
+DI 29.2895
-DI 15.8755
Chandelier Exit (Long, 3 ATRs ) 10.1159
Chandelier Exit (Short, 3 ATRs ) 11.7641
Upper Bollinger Band 11.625
Lower Bollinger Band 10.006
Percent B (%b) 0.95
BandWidth 14.969257
MACD Line 0.1307
MACD Signal Line 0.0324
MACD Histogram 0.0983
Fundamentals Value
Market Cap 262.04 Million
Num Shares 22.7 Million
EPS -2.22
Price-to-Earnings (P/E) Ratio -5.20
Price-to-Sales 4493.13
Price-to-Book 5.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.44
Resistance 3 (R3) 12.43 12.14 12.29
Resistance 2 (R2) 12.14 11.91 12.14 12.24
Resistance 1 (R1) 11.84 11.77 11.99 11.85 12.19
Pivot Point 11.55 11.55 11.62 11.55 11.55
Support 1 (S1) 11.25 11.32 11.40 11.26 10.91
Support 2 (S2) 10.96 11.18 10.96 10.86
Support 3 (S3) 10.66 10.96 10.81
Support 4 (S4) 10.67